1653 related articles for article (PubMed ID: 24014521)
1. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
4. Hybrid PET-MRI for early detection of dopaminergic dysfunction and microstructural degradation involved in Parkinson's disease.
Shang S; Li D; Tian Y; Li R; Zhao H; Zheng L; Zhang Y; Chen YC; Yin X
Commun Biol; 2021 Oct; 4(1):1162. PubMed ID: 34621005
[TBL] [Abstract][Full Text] [Related]
5. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
Schuff N; Wu IW; Buckley S; Foster ED; Coffey CS; Gitelman DR; Mendick S; Seibyl J; Simuni T; Zhang Y; Jankovic J; Hunter C; Tanner CM; Rees L; Factor S; Berg D; Wurster I; Gauss K; Sprenger F; Seppi K; Poewe W; Mollenhauer B; Knake S; Mari Z; McCoy A; Ranola M; Marek K
Mov Disord; 2015 Dec; 30(14):1885-92. PubMed ID: 26260437
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
[TBL] [Abstract][Full Text] [Related]
7. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
8. Fractional Anisotropy and Mean Diffusion as Measures of Dopaminergic Function in Parkinson's Disease: Challenging Results.
Lenfeldt N; Eriksson J; Åström B; Forsgren L; Mo SJ
J Parkinsons Dis; 2017; 7(1):129-142. PubMed ID: 28106567
[TBL] [Abstract][Full Text] [Related]
9. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
[TBL] [Abstract][Full Text] [Related]
10. Detecting dopaminergic neuronal degeneration using diffusion tensor imaging in a rotenone-induced rat model of Parkinson's disease: fractional anisotropy and mean diffusivity values.
Liu LX; Du D; Zheng T; Fang Y; Chen YS; Yi HL; He QY; Gao DW; Shi QL
Neural Regen Res; 2017 Sep; 12(9):1485-1491. PubMed ID: 29089995
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.
Zhang Y; Wu IW; Buckley S; Coffey CS; Foster E; Mendick S; Seibyl J; Schuff N
Mov Disord; 2015 Aug; 30(9):1229-36. PubMed ID: 25920732
[TBL] [Abstract][Full Text] [Related]
12. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
Bohnen NI; Gedela S; Kuwabara H; Constantine GM; Mathis CA; Studenski SA; Moore RY
J Neurol; 2007 Jan; 254(1):84-90. PubMed ID: 17508142
[TBL] [Abstract][Full Text] [Related]
13. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
[TBL] [Abstract][Full Text] [Related]
14. Commentary: olfactory dysfunction in Parkinson's disease.
Li J; Cui Y; Yuan TF; Arias-Carrion O
CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1079-80. PubMed ID: 24392859
[No Abstract] [Full Text] [Related]
15. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
[TBL] [Abstract][Full Text] [Related]
16. MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson's disease.
Wang J; Yang QX; Sun X; Vesek J; Mosher Z; Vasavada M; Chu J; Kanekar S; Shivkumar V; Venkiteswaran K; Subramanian T
Parkinsonism Relat Disord; 2015 Jun; 21(6):590-6. PubMed ID: 25825242
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.
Rinne JO; Ruottinen H; Bergman J; Haaparanta M; Sonninen P; Solin O
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):737-41. PubMed ID: 10567489
[TBL] [Abstract][Full Text] [Related]
18. Changes of olfactory tract in Parkinson's disease: a DTI tractography study.
Nigro P; Chiappiniello A; Simoni S; Paolini Paoletti F; Cappelletti G; Chiarini P; Filidei M; Eusebi P; Guercini G; Santangelo V; Tarducci R; Calabresi P; Parnetti L; Tambasco N
Neuroradiology; 2021 Feb; 63(2):235-242. PubMed ID: 32918150
[TBL] [Abstract][Full Text] [Related]
19. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
Hu MT; Scherfler C; Khan NL; Hajnal JV; Lees AJ; Quinn N; Wood NW; Brooks DJ
Mov Disord; 2006 Mar; 21(3):299-305. PubMed ID: 16211589
[TBL] [Abstract][Full Text] [Related]
20. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
